LncRNA MALAT1/microRNA let-7f/KLF5 axis regulates podocyte injury in diabetic nephropathy

Hu Zhang1, Yu Yan1, Qingfeng Hu2

  • 1Department of Endocrinology, Shangqiu First People's Hospital, Shangqiu 476100, Henan, China.

Life Sciences
|November 24, 2020
PubMed
Abstract

Insights

Reducing metastasis associated lung adenocarcinoma transcript 1 (MALAT1) alleviates diabetic nephropathy (DN) by increasing microRNA let-7f. This approach protects podocyte injury and offers a potential therapy for DN.

Area of Science:

  • Molecular biology
  • Genetics
  • Nephrology

Background:

  • Aberrant expression of microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) is implicated in human diseases.
  • Metastasis associated lung adenocarcinoma transcript 1 (MALAT1) and microRNA let-7f are investigated for their roles in diabetic nephropathy (DN).

Purpose of the Study:

  • To investigate the functions of MALAT1 and let-7f in diabetic nephropathy (DN).
  • To explore the therapeutic potential of targeting MALAT1 and let-7f in DN.

Main Methods:

  • Diabetes (db/db) mice treated with silenced MALAT1 to assess renal tissue changes and molecular markers.
  • Murine podocyte MPC5 cells exposed to high glucose (HG) and transfected with sh-MALAT1 or let-7f mimic to evaluate cell behavior.
  • Confirmed binding relationship between MALAT1 and let-7f, and targeting relationship between let-7f and krüppel-like factor 5 (KLF5).

Main Results:

  • Silenced MALAT1 improved DN mice indicators, renal pathology, podocyte injury markers (nephrin, podocin), and reduced markers of injury (desmin, Cleaved caspase-3).
  • Silenced MALAT1 restrained oxidative stress and inflammation in renal tissues of DN mice.
  • Elevated let-7f and reduced MALAT1 restricted migration and apoptosis, while promoting adhesion in HG-induced MPC5 cells.

Conclusions:

  • Reduced MALAT1 alleviates podocyte injury in DN by upregulating let-7f and inhibiting KLF5.
  • The MALAT1/let-7f/KLF5 axis presents a potential therapeutic target for diabetic nephropathy.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.5K